Mar 28, 2018 12:01 pm UTC| Business
NEW YORK, March 28, 2018 -- Minds (Minds.com), an open source social network and community-owned platform with over one-million users worldwide, today announced the launch of Minds Crypto Social Network, the most...
Del Taco Serves Up Growth Opportunities at Upcoming Multi-Unit Franchising Conference
Mar 28, 2018 12:01 pm UTC| Business
LAKE FOREST, Calif., March 28, 2018 -- Del Taco Restaurants, Inc. (NASDAQ:TACO), the nation’s second leading Mexican quick service restaurant,* invites franchisees attending the Multi-Unit Franchising Conference, taking...
MEDIA ALERT: Farsight Security CTO to Present at RSA® Conference 2018
Mar 28, 2018 12:01 pm UTC| Business
SAN MATEO, Calif., March 28, 2018 -- What: RSA Conference, one of the leading cybersecurity conferences in the world, is an opportunity to learn about new approaches to security, discover the latest technology and...
Beazley adds embedded workplace violence cover for its US insurer clients
Mar 28, 2018 12:01 pm UTC| Business
New York, March 28, 2018 -- Over two million Americans experience workplace violence each year, with potentially devastating consequences for organizations and individuals. The spectrum of risk is broad and campaigns...
Host Analytics Delivers First Ever Collaborative Budgeting and Forecasting Solution
Mar 28, 2018 12:01 pm UTC| Business
REDWOOD CITY, Calif., March 28, 2018 -- Host Analytics, the leading innovator of cloud-based enterprise performance management (EPM) solutions, today delivered the first ever collaborative planning, budgeting, and...
FDA Grants Orphan Drug Designation to Cynata’s Lead Cymerus™ MSC Product, CYP-001
Mar 28, 2018 12:01 pm UTC| Business
MELBOURNE, Australia, March 28, 2018 -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX:CYP) is pleased to announce that the United States Food and Drug Administration (FDA) has...
Aptose Biosciences Establishes New At-the-Market Facility
Mar 28, 2018 12:01 pm UTC| Business
SAN DIEGO and TORONTO, March 28, 2018 -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying...